MwanzoNBY • NYSEAMERICAN
add
NovaBay Pharmaceuticals Inc
$ 1.16
Baada ya Saa za Kazi:(1.73%)-0.020
$ 1.14
Imefungwa: 21 Okt, 19:54:41 GMT -4 · USD · NYSEAMERICAN · Kanusho
Bei iliyotangulia
$ 1.30
Bei za siku
$ 1.14 - $ 1.28
Bei za mwaka
$ 0.46 - $ 4.44
Thamani ya kampuni katika soko
6.97M USD
Wastani wa hisa zilizouzwa
elfu 996.40
Uwiano wa bei na mapato
7.24
Mgao wa faida
-
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | — | — |
Matumizi ya uendeshaji wa biashara | 1.89M | 16.94% |
Mapato halisi | -1.92M | -21.26% |
Kiwango cha faida halisi | — | — |
Mapato kwa kila hisa | — | — |
EBITDA | -1.89M | -17.32% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 5.34M | 611.58% |
Jumla ya mali | 6.91M | 76.08% |
Jumla ya dhima | 2.67M | -41.30% |
Jumla ya hisa | 4.24M | — |
hisa zilizosalia | 5.82M | — |
Uwiano wa bei na thamani | 1.78 | — |
Faida inayotokana na mali | -56.34% | — |
Faida inayotokana mtaji | -75.16% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -1.92M | -21.26% |
Pesa kutokana na shughuli | -2.95M | -408.45% |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | elfu -174.00 | 64.63% |
Mabadiliko halisi ya pesa taslimu | -3.12M | -191.32% |
Mtiririko huru wa pesa | -2.31M | -366.84% |
Kuhusu
NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on products for eye care. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis. and NeutroPhase, used in treatment of Necrotizing Fasciitis Wikipedia
Ilianzishwa
2000
Makao Makuu
Tovuti
Wafanyakazi
14
